Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 13, 2024

Total Value: $231M (100.0% shares, 0.0% debt)

Holdings (16)

EOLS EVOLUS INC 24.3%
Value $56.16M Shares 5,333,004 Share Price $10.53 * Est. Cost/Share $8.66 Unrealized @ Report Date +3.3%
ADMA ADMA BIOLOGICS INC 18.0%
Value $41.69M Shares 9,222,617 Share Price $4.52 * Est. Cost/Share $2.26 Unrealized @ Report Date +63.4%
AMLX AMYLYX PHARMACEUTICALS INC 15.9%
Value $36.8M Shares 2,500,000 Share Price $14.72 * Est. Cost/Share $23.76 Unrealized @ Report Date -35.5%
QDEL QUIDELORTHO CORP 14.3%
Value $33.16M Shares 450,000 Share Price $73.70 * Est. Cost/Share $89.16 Unrealized @ Report Date -24.2%
— ALIMERA SCIENCES INC 7.5%
Value $17.28M Shares 3,999,459 Share Price $4.32 Est. Cost/Share $3.10 Unrealized @ Report Date —
XERS XERIS BIOPHARMA HOLDINGS INC 6.0%
Value $13.95M Shares 5,937,000 Share Price $2.35 * Est. Cost/Share $2.16 Unrealized @ Report Date -14.4%
GLPG GALAPAGOS NV-SPON ADR 4.6%
Value $10.65M Shares 261,870 Share Price $40.65 Est. Cost/Share $39.25 Unrealized @ Report Date —
XOMA XOMA CORP 2.0%
Value $4.625M Shares 250,000 Share Price $18.50 * Est. Cost/Share $19.70 Unrealized @ Report Date -16.4%
IOBT IO BIOTECH INC 1.4%
Value $3.132M Shares 1,666,037 Share Price $1.88 * Est. Cost/Share $1.76 Unrealized @ Report Date -32.2%
SCYX SCYNEXIS INC 1.3%
Value $3.022M Shares 1,355,186 Share Price $2.23 * Est. Cost/Share $2.73 Unrealized @ Report Date -32.8%
RZLT REZOLUTE INC 1.2%
Value $2.748M Shares 2,768,656 Share Price $0.99 * Est. Cost/Share $3.88 Unrealized @ Report Date -76.4%
AVIR ATEA PHARMACEUTICALS INC 1.1%
Value $2.561M Shares 839,514 Share Price $3.05 Est. Cost/Share $3.68 Unrealized @ Report Date -17.6%
TELA TELA BIO INC 0.9%
Value $2.104M Shares 317,782 Share Price $6.62 * Est. Cost/Share $10.21 Unrealized @ Report Date -43.4%
AYTU AYTU BIOPHARMA INC 0.6%
Value $1.342M Shares 472,469 Share Price $2.84 * Est. Cost/Share $1.96 Unrealized @ Report Date +40.3%
XGN EXAGEN INC 0.6%
Value $1.333M Shares 669,684 Share Price $1.99 * Est. Cost/Share $8.92 Unrealized @ Report Date -80.6%
ATYR ATYR PHARMA INC 0.3%
Value $680K Shares 482,258 Share Price $1.41 * Est. Cost/Share $2.19 Unrealized @ Report Date -41.5%